The Brain Imaging Race Heats Up — Bay Imaging Lands Strategic Round to Scale Next-Gen Brain PET
Details
$1.5 Billion Blockbuster: Dizal Hands Sunvozertinib Global Keys to AstraZeneca
Sonosemi Raises Series B+ Financing to Accelerate Global Expansion in Intelligent Vascular Intervention
Novartis to Acquire Myricx Bio for Up to $1.1B, Strengthening Next-Generation ADC Innovation
$62 million Series B financing to develop a licensed trispecific T-cell engager (TCE) from Leads Biolabs.
Nearly $2 Billion Deal! Chinese-Origin TCE Secures Another Overseas Licensing Agreement
U-Yi Biotech Raises Tens of Millions of RMB in Series A Financing to Expand Serum-Free Culture Media Platform
June 26 2026Haisco Licenses Two Clinical-Stage Small-Molecule Assets to Nuvectis in Deal Worth Up to US$1.46 Billion
Barty Medical Raises Nearly RMB 200 Million in Series D Financing to Accelerate Commercialization of Vascular Interventional Devices
Over US$1 Billion! Eli Lilly Licenses AlzeCure’s Alzheimer’s Small-Molecule Candidate ACD680
